Loading clinical trials...
Loading clinical trials...
SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder (OUD), Quality of Life (QOL), and housing outcomes for homeless patients receiving Medicatio...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Maryland, Baltimore
NCT03745339 · Opioid-Related Disorders, Drug Addiction
NCT05336188 · Opioid-Related Disorders, Mobile Applications, and more
NCT05651516 · Opioid-Related Disorders
NCT05505227 · Opioid-Related Disorders, Buprenorphine, and more
NCT05657106 · Opioid-Related Disorders, Hepatitis C (HCV), and more
University of Maryland Addiction Treatment Program (ATP)
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions